Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | MXCTMaxcyte, Inc.FY2025 · Dec |
|---|---|
| Revenue | $33.03M |
| Revenue, yoy | −14.5% |
| Net income | $44.63M |
| Net income, yoy | −8.7% |
| Net margin | -135.1% |
| Free cash flow | $36.18M |
| FCF margin | -109.5% |
| EPS, diluted | $0.42 |
Add another company.